Board of Directors 2024-2025
President (2024-2025)
Eberechukwu Onukwugha, PhD
Professor, University of Maryland
Baltimore, Maryland, USA
Past President (2024-2025)
Brian O'Rourke, PharmD, CD, OMM
President, Brian O'Rourke Health Care Consulting, Inc
Ottawa, Canada
President-Elect (2024-2025)
Uwe Siebert, MD, MPH, ScD
Professor for Public Health, Medical Decision Making and Health Technology Assessment
UMIT TIROL - University for Health Sciences and Technology
Tirol, Austria
Director (2023-2026)
Dalia Dawoud, PhD
Associate Director (Research), The National Institute for Health and Care Excellence (NICE)
London, England, UK
Biography and Vision Statement
Director (2024-2027)
Elisabeth Fenwick, PhD, MSc
Chief Science Officer
Open Health Group
London, England, UK
Director (2024-2027)
Ramiro Gilardino, MD, MHS
Global HTA & Access Policy Lead at Global Access
MSD International
Zurich, Switzerland
Director (2024-2027)
Daniel Ollendorf, PhD
Chief Scientific Officer and Director of HTA Methods and Engagement
Institute for Clinical and Economic Review
Boston, MA, USA
Director (2023-2026)
Lucinda Orsini, DPM, MPH
Vice President for Value and Outcomes Research, COMPASS Pathways
Skillman, New Jersey, USA
Biography and Vision Statement
Director (2023-2026)
Amy O’Sullivan, PhD
Senior Vice President and Chief Scientific Officer, Ontada
Boston, Massachusetts, USA
Biography and Vision Statement
Director (2024-2027)
Katja Rudell, PhD, MSc
Senior Director
Parexel International
London, England, UK
Treasurer (2020-2026)
Sean D. Sullivan, BScPharm, MSc, PhD,
Professor and Dean, University of Washington, School of Pharmacy
Seattle, Washington, USA
CEO & Executive Director
Rob Abbott
CEO & Executive Director
ISPOR-The Professional Society for Health Economics and Outcomes Research
Lawrenceville, New Jersey, USA